Cartiva raises $8.5M in Series D round


What does Cartiva do?

Cartiva, is an innovative products developer for treatment of osteoarthritis and cartilage injuries. It is a venture capital backed company which has spun out from Carticept Medical in December 2011. This company is dedicated to improvement of quality of life for osteoarthritis or cartilage damage patients by developing novel therapies.

It is estimated that 27M Americans suffer from osteoarthritis, which is chronic degenerative disease of the joints, which is characterize by cartilage breakdown. Apart from this around 2 M people suffer knee cartilage injuries. Many people do not respond well to the medicines and they are not eligible for major surgery such as total replacement of the joint. Its mission is developing and marketing products which help physicians to treat osteoarthritis and cartilage injuries and any pain which is associate with them more effectively.

How much Cartiva was funded?

Cartiva raised $8.5M in Series D round on May 11th, 2015 from New Enterprise Associates and Windham Venture Partners.

Previous funding

  • $4.3M in Series A funding on July 15, 2013 from New Enterprise Associates
  • $1.5M in Debt Financing on January 8, 2014 from Silicon Valley Bank
  • $1.5M in Venture round on December 29, 2014

What is next for Cartiva?

Cartiva is on a mission of developing and marketing products which help physicians in treating osteoarthritis and cartilage injuries and related pain effectively. The funding will be used to help the company through PMA approval of its Cartiva Synthetic Cartilage Implant. The funding will also help the post 510(K) clearance clinical evaluations of the ProxiFuse Hammertoe Correction System and its GRIP Study evaluating Cartiva SCI in osteoarthritis treatment at the base of the thumb.

More about Cartiva

Cartiva was founded on January 1st, 2011 and has its headquarters in Alpharetta, GA. It develops and markets innovative solutions for patients suffering from cartilage damage, osteoarthritis and other musculoskeletal conditions.